FDA advisers support booster dose of Pfizer vaccine in older or high-risk adults

A Food and Drug Administration advisory panel on Friday unanimously supported giving a third shot of Pfizer and BioNTech's coronavirus vaccine to older adults or to those at high risk of severe COVID-19, but rejected a plan to roll out booster shots more broadly.